Clinical Factors Affecting Constipation in Patients with Schizophrenia Taking Clozapine
Open Access
- 30 October 2022
- journal article
- research article
- Published by Korean Society for Schizophrenia Research in Korean Journal of Schizophrenia Research
- Vol. 25 (2) , 54-61
Abstract
Objectives: To investigate clinical factors affecting constipation in patients with schizophrenia taking clozapine.Methods: The participants were patients with schizophrenia taking clozapine and tested for the Therapeutic Drug Monitoring from September 1, 2020 to July 1, 2022 at a university hospital. To evaluate the effect of clozapine on constipation, clozapine dosage, clozapine concentration, and norclozapine concentration were investigated. To evaluate effects of drugs other than clozapine on constipation, dosage and type of other drug were investigated. Anticholinergic Drug Scale was used to evaluate anticholinergic action.Results: A total of 56 patients were enrolled in the study. Clozapine daily dose, clozapine concentration, and norclozapine concentration were higher in the constipated patient group. Through logistic regression analysis, it was discovered that the risk of constipation increased as the norclozapine concentration increased, and the results remained similarly even after adjustments of related variables was performed.Conclusion: It was discoverd that among patients taking clozapine, the higher the norclozapine concentration, the higher the probability of constipation. Among patients taking clozapine, patients with high norclozapine concentration may need additional evaluation and management of constipation.Keywords
This publication has 32 references indexed in Scilit:
- Risk Factors for Ileus in Patients with SchizophreniaSchizophrenia Bulletin, 2010
- International Consensus Study of Antipsychotic DosingAmerican Journal of Psychiatry, 2010
- Agonist activity of N-desmethylclozapine at δ-opioid receptors of human frontal cortexEuropean Journal of Pharmacology, 2009
- Interrater reliability of the Antipsychotic Non-Neurological Side-Effects Rating Scale measured in patients treated with clozapineJournal of Psychopharmacology, 2008
- Pharmacology of N-desmethylclozapine☆Pharmacology & Therapeutics, 2007
- A Population-Based Study on Bowel Habits in a Korean Community: Prevalence of Functional Constipation and Self-Reported ConstipationDigestive Diseases and Sciences, 2006
- Serum Antimuscarinic Activity During Clozapine TreatmentJournal of Clinical Psychopharmacology, 2003
- Improved Efficacy and Fewer Side Effects Under Clozapine Treatment After Addition of FluvoxamineJournal of Clinical Psychopharmacology, 1995
- Clozapine-Induced Agranulocytosis -- Incidence and Risk Factors in the United StatesNew England Journal of Medicine, 1993
- Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonistsEuropean Journal of Pharmacology: Molecular Pharmacology, 1993